Putrescine
|
Basic information |
| Metabolite name | Putrescine |
 | HMDB0001414 |
 |
C00134 |
 |
1045 |
| Synonyms | 1,4-butanediamine |
| No. of studies | 18 |
|
Basic information |
| Metabolite name | Putrescine |
| HMDB0001414 |
|
C00134 |
|
1045 |
| Synonyms | 1,4-butanediamine |
| No. of studies | 18 |
|
Relationship between Putrescine and depression (count: 18) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M067 | Type1 | naturally-occurring depression group vs. control group | Serum | Cynomolgus monkey | Down |
| Study M077 | Type1 | non-weaned FST group vs. weaned FST group | Urine | Wistar rat | Up |
| Study M077 | Type1 | non-weaned group vs. weaned group | Urine | Wistar rat | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M155 | Type1 | depressed suicide group vs. control group | Frontal cortex | Human | Up |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M480 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Down |
| Study M480 | Type2 | CGA-treated group vs. sleep deprivation group | Urine | Wistar rat | Up |
| Study M514 | Type3 | ketamine group vs. vehicle group at 2 h | Hippocampus | C57BL/6 mouse | Up |
| Study M536 | Type1 | naturally-occurring depression group vs. control group | Cerebrospinal fluid | Cynomolgus monkey | Up |
| Study M556 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Down |
| Study M602 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Serum | C57BL/6 J mouse | Up |
| Study M614 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M840 | Type1 | A1/A2 beta-casein group vs. control group | Urine | Wistar rat | Up |
| Study M840 | Type1 | casein-rich milk group vs. control group | Urine | Wistar rat | Up |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M894 | Type2 | electromagnetic field exposure + heat acclimation group vs. electromagnetic field exposure group | Serum | C57BL/6J mouse | Down |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Cerebrospinal fluid | Human | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Down |